Cash Flow - Spyre Therapeutics, Inc. (SYRE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -169.25 | -157.41 | -99.91 | -80.14 | -53.72 | -75.78 | -65.69 | -32.19 | -24.62 | -18.84 | -10.98 | -7.34 |
| Cash flow from investing | -143.48 | -353.29 | 57.01 | -22.62 | -7.60 | -1.74 | -15.23 | -22.53 | -12.16 | -4.01 | -0.22 | |
| Cash flow from financing | 309.03 | 410.91 | 361.08 | 42.68 | 1.39 | 154.51 | 65.72 | 57.07 | 12.21 | 49.37 | 41.67 | 5.58 |
| Change in cash | -3.70 | -99.79 | 261.17 | 19.54 | -74.94 | 71.13 | -1.71 | 9.64 | -34.93 | 18.37 | 26.68 | -1.98 |
Show Quarterly Cash Flow
Cash Flow - Spyre Therapeutics, Inc. (SYRE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | Dec-17 | Sep-17 | Jun-17 | Mar-17 | Dec-16 | Sep-16 | Jun-16 | Mar-16 | Dec-15 | Sep-15 | Jun-15 | Mar-15 | Dec-14 | Sep-14 | Jun-14 | Mar-14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -57.54 | -44.58 | -37.12 | -46.56 | -40.99 | -37.20 | -29.42 | -62.25 | -28.54 | -31.04 | -34.60 | -16.64 | -17.63 | -18.14 | -15.07 | -20.67 | -26.26 | -19.27 | -17.00 | 2.08 | -19.53 | -17.13 | -17.54 | -19.41 | -21.69 | -16.29 | -17.21 | -16.38 | -15.81 | -7.20 | -8.50 | -9.04 | -7.45 | -5.87 | -7.37 | -5.94 | -5.43 | -4.36 | -5.87 | -4.63 | -3.99 | -0.83 | -3.81 | -3.86 | -2.48 | -2.98 | -1.80 | -1.22 | -1.34 |
| Cash flow from investing | 56.58 | -247.41 | 25.00 | 79.00 | -0.06 | -170.54 | 42.74 | -120.52 | -104.96 | -35.27 | -97.63 | 6.76 | 17.75 | 14.00 | 16.50 | 0.75 | 25.76 | 9.66 | 5.78 | -47.36 | 9.30 | 28.62 | 5.78 | -56.76 | 14.75 | 10.33 | 16.01 | -42.01 | 13.94 | -2.13 | 1.40 | -19.20 | 4.70 | 4.84 | -6.29 | 4.52 | -25.61 | 2.56 | -15.30 | 1.85 | -1.19 | -0.51 | -3.46 | -0.02 | -0.02 | -0.11 | -0.07 | -0.01 | -0.03 |
| Cash flow from financing | 12.43 | 312.81 | -4.64 | 0.73 | 0.13 | 225.60 | 12.78 | 0.36 | 172.17 | 163.61 | -12.53 | 209.99 | 0.01 | -0.01 | -0.13 | 42.80 | 0.01 | 0.08 | 1.14 | -0.19 | 0.36 | 24.68 | 0.26 | 129.29 | 0.28 | 0.68 | 0.31 | -0.32 | 65.06 | 17.26 | 1.06 | 38.06 | 0.69 | 0.68 | -0.12 | 11.55 | 0.10 | 0.08 | 49.39 | -0.10 | -0.20 | -0.97 | -0.83 | 43.68 | 5.58 | ||||
| Change in cash | 11.46 | 20.82 | -16.76 | 33.17 | -40.93 | 17.86 | 26.10 | -182.41 | 38.66 | 97.30 | -144.76 | 200.11 | 0.13 | -4.15 | 1.30 | 22.88 | -0.49 | -9.53 | -10.08 | -45.47 | -9.87 | 36.17 | -11.49 | 53.12 | -6.66 | -5.29 | -0.89 | -58.72 | 63.18 | 7.93 | -6.05 | 9.82 | -2.06 | -0.35 | -13.77 | 10.13 | -30.95 | -1.80 | -21.08 | 46.61 | -5.28 | -1.55 | -8.24 | -4.71 | 41.18 | -3.09 | 3.70 | -1.22 | -1.37 |